61. Inhibition of Novel Reassortant Avian Influenza H7N9 Virus Infection in vitro with Three Antiviral Drugs, Oseltamivir, Peramivir and Favipiravir. Issue 6 (December 2014) Authors: Cao, Rui-Yuan; Xiao, Jun-Hai; Cao, Bin; Li, Song; Kumaki, Yohichi; Zhong, Wu Journal: Antiviral chemistry & chemotherapy Issue: Volume 23:Issue 6(2014) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs. (August 2021) Authors: Zheng, Wenxiao; D'Aiuto, Leonardo; Demers, Matthew J; Muralidaran, Vaishali; Wood, Joel A; Wesesky, Maribeth; Chattopadhyay, Ansuman; Nimgaonkar, Vishwajit L Journal: Antiviral chemistry & chemotherapy Issue: Volume 29(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz. Issue 3 (December 2017) Authors: Jordaan, Maryam A; Shapi, Michael Journal: Antiviral chemistry & chemotherapy Issue: Volume 25:Issue 3(2017) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative. Issue 5 (December 2015) Authors: Ito, Wataru; Toyama, Masaaki; Okamoto, Mika; Ikeda, Masanori; Watashi, Koichi; Wakita, Takaji; Hashimoto, Yuichi; Baba, Masanori Journal: Antiviral chemistry & chemotherapy Issue: Volume 24:Issue 5/6(2015) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Killing HIV-infected resting central memory CD4+ T cells by targeting inhibitor of apoptosis proteins-inhibited autophagy. (February 2021) Authors: Zhang, Gang; Huang, Xing Journal: Antiviral chemistry & chemotherapy Issue: Volume 29(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA. Issue 1 (June 2018) Authors: Vere Hodge, R Anthony Journal: Antiviral chemistry & chemotherapy Issue: Volume 26:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Meeting report: 34th international conference on antiviral research. (October 2022) Authors: Brancale, Andrea; Carter, Kara; Delang, Leen; Deval, Jerome; Durantel, David; Gentry, Brian G; Jordan, Robert; Julander, Justin G.; Lo, Michael K.; Pérez-Pérez, Maria-Jesús; Schang, Luis M.; Seley-Radtke, Katherine L.; Shi, Pei-Yong; Vasudevan, Subhash G.; Whitley, Richard J.; Spengler, Jessica R. Journal: Antiviral chemistry & chemotherapy Issue: Volume 30(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus. Issue 3 (August 2015) Authors: Montiel, Milagros; Bonilla, Ernesto; Valero, Nereida; Mosquera, Jesús; Espina, Luz M; Quiroz, Yasmir; Álvarez-Mon, Melchor Journal: Antiviral chemistry & chemotherapy Issue: Volume 24:Issue 3/4(2015) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Memantine treatment reduces the incidence of flaccid paralysis in a zika virus mouse model of temporary paralysis with similarities to Guillain-Barré syndrome. (August 2020) Authors: Siddharthan, Venkatraman; Wang, Hong; de Oliveira, Alexandre LR; Dai, Xin; Morrey, John D Journal: Antiviral chemistry & chemotherapy Issue: Volume 28(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Issue 2 (August 2017) Authors: Masson, Jesse JR; Billings, Hugh WW; Palmer, Clovis S Journal: Antiviral chemistry & chemotherapy Issue: Volume 25:Issue 2(2017) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗